Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-24

Clinical Trial Update: S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone

View source ↗

Summary

A completed clinical trial update focusing on blood and tissue samples from patients with follicular lymphoma treated with Rituximab, Cyclophosphamide, Doxorubi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
  • PREDNISONE (Prednisone)
  • Rituxan (rituximab)
  • Vincristine (vincristine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Status: COMPLETED